Total Funding
42
3
Total FundingVenture - Series Unknown raised
Growth Score 42 in past quarter
-5 pts
Heat Score 3 in past quarter
-40 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
323487
Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression
Anne-Marie Wenthzel: Vice President Business Development- Erik Kinnman: Chief Executive OfficerPast Role: Abliva AB, CEO
About the Company
Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression and purification, fragment screening, X-ray crystallography, and expansion of fragments into a patented lead series. Sprint Bioscience is based in Stockholm, Sweden.

